LIGAND PHARMACEUTICALS INC short interest in 2025
In 2025, LIGAND PHARMACEUTICALS INC's disclosed short interest ran from 4.82% of shares outstanding on 15 Jan 2025 to 6.33% on 31 Dec 2025, a change of +1.51 percentage points. The year's high was 6.40% on 15 Jul 2025 and its low 4.05% on 28 Feb 2025, averaging 5.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.49 days on 14 Feb 2025. Full history: LIGAND PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 4.82% (15 Jan 2025)
- End of year
- 6.33% (31 Dec 2025)
- Change
- +1.51 pp
- High
- 6.40% (15 Jul 2025)
- Low
- 4.05% (28 Feb 2025)
- Average
- 5.61%
- Highest days to cover
- 12.49 (14 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 4.82% | 9.41 | |
| 31 Jan 2025 | 5.04% | 11.85 | |
| 14 Feb 2025 | 4.47% | 12.49 | |
| 28 Feb 2025 | 4.05% | 6.17 | results (8-K), 10-K filed |
| 14 Mar 2025 | 4.96% | 7.09 | |
| 31 Mar 2025 | 5.24% | 7.46 | |
| 15 Apr 2025 | 5.94% | 9.12 | |
| 30 Apr 2025 | 6.34% | 12.27 | |
| 15 May 2025 | 5.65% | 8.85 | results (8-K), 10-Q filed |
| 30 May 2025 | 6.37% | 11.48 | |
| 13 Jun 2025 | 5.98% | 10.02 | |
| 30 Jun 2025 | 6.16% | 7.39 | |
| 15 Jul 2025 | 6.40% | 9.65 | |
| 31 Jul 2025 | 4.75% | 4.14 | |
| 15 Aug 2025 | 6.09% | 2.71 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 5.89% | 7.96 | |
| 15 Sep 2025 | 5.72% | 5.71 | |
| 30 Sep 2025 | 6.10% | 4.58 | |
| 15 Oct 2025 | 6.03% | 9.37 | |
| 31 Oct 2025 | 5.65% | 7.24 | |
| 14 Nov 2025 | 5.34% | 4.24 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 5.63% | 4.81 | |
| 15 Dec 2025 | 5.57% | 4.77 | |
| 31 Dec 2025 | 6.33% | 6.81 |
See also: LIGAND PHARMACEUTICALS INC's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.